Heidy King-Jones

SYRE

Heidy King-Jones serves as officer: See Remarks at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$5.11M

Net Position

Net Seller

$5.11M

Companies Traded

SYRE

Active Period

Sep 2026 – Oct 2026

2 total trades

Most Recent

Sell SYRE

Oct 2, 2026 · $2.63M

Heidy King-Jones's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

2 · $5.11M

Total Shares Bought

Total Shares Sold

57,332

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 2, 2026	Sell	28,933	$91.03	$2.63M	31,378
Sep 3, 2026	Sell	28,399	$87.35	$2.48M	25,999

Related Insiders

Scott L Burrows

officer: Chief Financial Officer

SYRESell · Oct 2, 2026

Cameron Turtle

director, officer: Chief Executive Officer

SYRESell · Oct 2, 2026

Jeffrey W. Albers

director

SYRESell · Aug 10, 2026

Sheldon Sloan

officer: Chief Medical Officer

SYRESell · Jul 2, 2026

Fairmount Funds Management LLC

director

SYRESell · Jun 23, 2026

HENDERSON MICHAEL THOMAS

director

SYRESell · Jun 23, 2026

Explore More Insider Trading Data

SYRE Insider Trading Activity

View all insider trades at Spyre Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity